Brcic L, Brcic I, Staresinic M, et al
I became obsessed to find out the truth, so I put on my Nancy Drew hat, and now were here
Self-administration of research peptides carries inherent risks including contamination, incorrect dosing, and unknown long-term effects
- Most evidence comes from animal studies - Human data is extremely limited - No FDA approval for orthopedic use - Clinical benefit in musculoskeletal conditions remains unproven While the biology is interesting, potential does not equal proven clinical outcomes
Six randomized, double-blind, placebo-controlled trials involving over 900 participants demonstrated that this growth hormone fragment peptide is well-tolerated with a safety profile indistinguishable from placebo